Macrophage activation syndrome after treatment with infliximab for fistulated Crohn's disease;Syndrome d'activation macrophagique après traitement par infliximab pour maladie de Crohn fistulisée

Presse Medicale

Volumn 34, Issue 8, 2005, Pages 583-584

  Chauveau, Éric ^a   Terrier, François ^b   Casassus Buihle, Didier ^b   Moncoucy, Xavier ^b   Oddes, Bernard ^b  

^a HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INFLIXIMAB; PHOSPHATIDYLETHANOLAMINE;

ADULT; ARTICLE; CASE REPORT; CROHN DISEASE; FEVER; HUMAN; HYPERFERRITINEMIA; HYPERTRIGLYCERIDEMIA; INJECTION; MACROPHAGE ACTIVATION; MALE; PANCYTOPENIA; SIDE EFFECT; SYNDROME;

EID: 18444406875     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)83984-3     Document Type: Article

References (6)

1. Van Dullemen HM, van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GN et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129-35.
2. Fisman DN. Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6: 601-8.
3. Reiner AP, Spivak JL. Hematophagic histiocytosis. A report of 23 new patients and a review of the literature. Medicine 1988; 67: 369-88.
4. Nunez Martinez O, Ripoll Noiseux C, Carneros Martin JA, Gonzales Lara V, Gregorio Maranon HG. Reactivation tuberculosis in a patient with anti-TNF-alpha treatment. Am J Gastroenterol 2001; 96: 1665-6.
5. Nakelchik M, Mangino JE. Reactivation of histoplasmosis after treatment with infliximab. Am J Med 2002; 112: 78.
6. Lay JD, Tsao Q, Chen JY, Kadin ME, Su JJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997; 100: 1969-79.